anitocabtagene autoleucel (CART-ddBCMA) / Arcellx, Gilead 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
anitocabtagene autoleucel (CART-ddBCMA) / Arcellx, Gilead
iMMagine-3, NCT06413498: A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Recruiting
3
450
Europe, US, RoW
Anitocabtagene Autoleucel, CART-ddBCMA, Cyclophosphamide, Fludarabine, Pomalidomide, Bortezomib, Dexamethasone, Daratumumab, Carfilzomib
Kite, A Gilead Company, Arcellx, Inc.
Multiple Myeloma
07/28
07/31
iMMagine-1, NCT05396885: Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma

Recruiting
2
110
US
anitocabtagene-autoleucel, CART-ddBCMA
Kite, A Gilead Company, Arcellx, Inc.
Multiple Myeloma
05/24
05/25
NCT05041309 / 2020-005843-21: Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Enrolling by invitation
2
1000
Europe, Canada, Japan, US, RoW
Axicabtagene Ciloleucel, Yescarta®, Brexucabtagene Autoleucel, Tecartus™, Anitocabtagene autleucel, CART-ddBCMA, KITE-753, KITE-197, KITE-363
Kite, A Gilead Company, Kite Pharma, Inc.
Solid and Hematological Malignancies
12/40
12/40
ARC-101, NCT04155749: Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma

Active, not recruiting
1
40
US
anitocabtagene-autoleucel
Kite, A Gilead Company, Arcellx, Inc.
Relapsed and Refractory Multiple Myeloma
08/24
11/35
NCT06626919: A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Recruiting
1
30
US
anito-cel, anitocabtagene autoleucel, CART-ddBCMA, Standard Lymphodepletion regimen, Cyclophosphamide, Fludarabine
Arcellx, Inc.
Muscular Diseases, Neuromuscular Manifestations, Autoimmune, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Myasthenia Gravis, Muscle Weakness
03/27
04/28

Download Options